Evidence map›Paper›PMID 29487778›Full record

Review3 Biotech2018

Fundamentals and commercial aspects of nanobiosensors in point-of-care clinical diagnostics.

Kuldeep Mahato, Pawan Kumar Maurya, Pranjal Chandra

Abstract readReview
In one paragraph

Review in 3 Biotech, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Bioelectronics forNanotheranostics · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Integrating bio medical sensors in detecting hidden signatures of COVID-19 with Artificial intelligence.Measurement : journal of the International Measurement Confederation · 2022
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Synthesis of NiRSC advances · 2020
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kuldeep Mahato1Department of Bioscience and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039 India.
Pawan Kumar Maurya2Amity Institute of Biotechnology, Amity University, Sector-125, Noida, Uttar Pradesh 201307 India.
Pranjal Chandra1Department of Bioscience and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among various problems faced by mankind, health-related concerns are prevailing since long which are commonly found in the form of infectious diseases and different metabolic disorders. The clinical cure and management of such abnormalities are greatly dependent on the availability of their diagnoses. The conventional diagnostics used for such purposes are extremely powerful; however, most of these are limited by time-consuming protocols and require higher volume of test sample, etc. A new evolving technology called "biosensor" in this context shows an enormous potential for an alternative diagnostic device, which constantly compliments the conventional diagnoses. In this review, we have summarized different kinds of biosensors and their fundamental understanding with various state-of-the-art examples. A critical examination of different types of biosensing mechanisms is also reported highlighting the advantages of electrochemical biosensors for its great potentials in next-generation commercially viable modules. In recent years, a number of nanomaterials are extensively used to enhance not only the performance of biosensing mechanism, but also obtain robust, cheap, and fabrication-friendly durable mechanism. Herein, we have summarized the importance of nanomaterials in biosensing mechanism, their syntheses as well as characterization techniques. Subsequently, we have discussed the probe fabrication processes along with various techniques for assessing its analytical performances and potentials for commercial viability.

Indexed as

BiosensorCommercializationHealthcareNanomaterialPoint-of-care detection

Identifiers

PMID29487778
PMCPMC5823794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.